158 related articles for article (PubMed ID: 15734052)
1. Development of transgenic alfalfa plants containing the foot and mouth disease virus structural polyprotein gene P1 and its utilization as an experimental immunogen.
Dus Santos MJ; Carrillo C; Ardila F; Ríos RD; Franzone P; Piccone ME; Wigdorovitz A; Borca MV
Vaccine; 2005 Mar; 23(15):1838-43. PubMed ID: 15734052
[TBL] [Abstract][Full Text] [Related]
2. Orally delivered foot-and-mouth disease virus capsid protomer vaccine displayed on T4 bacteriophage surface: 100% protection from potency challenge in mice.
Ren ZJ; Tian CJ; Zhu QS; Zhao MY; Xin AG; Nie WX; Ling SR; Zhu MW; Wu JY; Lan HY; Cao YC; Bi YZ
Vaccine; 2008 Mar; 26(11):1471-81. PubMed ID: 18289743
[TBL] [Abstract][Full Text] [Related]
3. Immunogenicity of foot-and-mouth disease virus structural polyprotein P1 expressed in transgenic rice.
Wang Y; Shen Q; Jiang Y; Song Y; Fang L; Xiao S; Chen H
J Virol Methods; 2012 Apr; 181(1):12-7. PubMed ID: 22274594
[TBL] [Abstract][Full Text] [Related]
4. Development of replication-defective adenovirus serotype 5 containing the capsid and 3C protease coding regions of foot-and-mouth disease virus as a vaccine candidate.
Mayr GA; Chinsangaram J; Grubman MJ
Virology; 1999 Oct; 263(2):496-506. PubMed ID: 10544121
[TBL] [Abstract][Full Text] [Related]
5. Induction of a protective antibody response to foot and mouth disease virus in mice following oral or parenteral immunization with alfalfa transgenic plants expressing the viral structural protein VP1.
Wigdorovitz A; Carrillo C; Dus Santos MJ; Trono K; Peralta A; Gómez MC; Ríos RD; Franzone PM; Sadir AM; Escribano JM; Borca MV
Virology; 1999 Mar; 255(2):347-53. PubMed ID: 10069960
[TBL] [Abstract][Full Text] [Related]
6. DNA vaccination against foot-and-mouth disease via electroporation: study of molecular approaches for enhancing VP1 antigenicity.
Kim SA; Liang CM; Cheng IC; Cheng YC; Chiao MT; Tseng CJ; Lee F; Jong MH; Tao MH; Yang NS; Liang SM
J Gene Med; 2006 Sep; 8(9):1182-91. PubMed ID: 16927362
[TBL] [Abstract][Full Text] [Related]
7. [Expression of foot and mouth disease virus antigens in transgenic plants].
Dus Santos MJ; Wigdorovitz A
Rev Sci Tech; 2005 Apr; 24(1):175-87. PubMed ID: 16110887
[TBL] [Abstract][Full Text] [Related]
8. Foliar extracts from transgenic tomato plants expressing the structural polyprotein, P1-2A, and protease, 3C, from foot-and-mouth disease virus elicit a protective response in guinea pigs.
Pan L; Zhang Y; Wang Y; Wang B; Wang W; Fang Y; Jiang S; Lv J; Wang W; Sun Y; Xie Q
Vet Immunol Immunopathol; 2008 Jan; 121(1-2):83-90. PubMed ID: 18006078
[TBL] [Abstract][Full Text] [Related]
9. Recombinant adenovirus expressing type Asia1 foot-and-mouth disease virus capsid proteins induces protective immunity against homologous virus challenge in mice.
Zhou G; Wang H; Wang F; Yu L
Res Vet Sci; 2013 Jun; 94(3):796-802. PubMed ID: 23267820
[TBL] [Abstract][Full Text] [Related]
10. Induction of protective immunity in swine by immunization with live attenuated recombinant pseudorabies virus expressing the capsid precursor encoding regions of foot-and-mouth disease virus.
Li X; Liu R; Tang H; Jin M; Chen H; Qian P
Vaccine; 2008 May; 26(22):2714-22. PubMed ID: 18436351
[TBL] [Abstract][Full Text] [Related]
11. Protection of mice against challenge with foot and mouth disease virus (FMDV) by immunization with foliar extracts from plants infected with recombinant tobacco mosaic virus expressing the FMDV structural protein VP1.
Wigdorovitz A; Pérez Filgueira DM; Robertson N; Carrillo C; Sadir AM; Morris TJ; Borca MV
Virology; 1999 Nov; 264(1):85-91. PubMed ID: 10544132
[TBL] [Abstract][Full Text] [Related]
12. Construction and immunogenicity of a recombinant fowlpox virus containing the capsid and 3C protease coding regions of foot-and-mouth disease virus.
Zheng M; Jin N; Zhang H; Jin M; Lu H; Ma M; Li C; Yin G; Wang R; Liu Q
J Virol Methods; 2006 Sep; 136(1-2):230-7. PubMed ID: 16780963
[TBL] [Abstract][Full Text] [Related]
13. Novel expression of immunogenic foot-and-mouth disease virus-like particles in Nicotiana benthamiana.
Veerapen VP; van Zyl AR; Wigdorovitz A; Rybicki EP; Meyers AE
Virus Res; 2018 Jan; 244():213-217. PubMed ID: 29196195
[TBL] [Abstract][Full Text] [Related]
14. Induction of a virus-specific antibody response to foot and mouth disease virus using the structural protein VP1 expressed in transgenic potato plants.
Carrillo C; Wigdorovitz A; Trono K; Dus Santos MJ; Castañón S; Sadir AM; Ordas R; Escribano JM; Borca MV
Viral Immunol; 2001; 14(1):49-57. PubMed ID: 11270596
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity of plasmids encoding P12A and 3C of FMDV and swine IL-18.
Mingxiao M; Ningyi J; Juan LH; Min Z; Guoshun S; Guangze Z; Huijun L; Xiaowei H; Minglan J; Xu L; Haili M; Yue J; Gefen Y; Kuoshi J
Antiviral Res; 2007 Oct; 76(1):59-67. PubMed ID: 17606304
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity of the epitope of the foot-and-mouth disease virus fused with a hepatitis B core protein as expressed in transgenic tobacco.
Huang Y; Liang W; Wang Y; Zhou Z; Pan A; Yang X; Huang C; Chen J; Zhang D
Viral Immunol; 2005; 18(4):668-77. PubMed ID: 16359233
[TBL] [Abstract][Full Text] [Related]
17. Past and present vaccine development strategies for the control of foot-and-mouth disease.
Balamurugan V; Kumar RM; Suryanarayana VV
Acta Virol; 2004; 48(4):201-14. PubMed ID: 15745043
[TBL] [Abstract][Full Text] [Related]
18. A novel methodology to develop a foot and mouth disease virus (FMDV) peptide-based vaccine in transgenic plants.
Dus Santos MJ; Wigdorovitz A; Trono K; Ríos RD; Franzone PM; Gil F; Moreno J; Carrillo C; Escribano JM; Borca MV
Vaccine; 2002 Jan; 20(7-8):1141-7. PubMed ID: 11803075
[TBL] [Abstract][Full Text] [Related]
19. A novel bi-functional DNA vaccine expressing VP1 protein and producing antisense RNA targeted to 5'UTR of foot-and-mouth disease virus can induce both rapid inhibitory effect and specific immune response in mice.
Yang B; Lan X; Li X; Yin X; Li B; Han X; Li Y; Zhang Z; Liu J
Vaccine; 2008 Oct; 26(43):5477-83. PubMed ID: 18694793
[TBL] [Abstract][Full Text] [Related]
20. HSV-1 amplicon vectors that direct the in situ production of foot-and-mouth disease virus antigens in mammalian cells can be used for genetic immunization.
D'Antuono A; Laimbacher AS; La Torre J; Tribulatti V; Romanutti C; Zamorano P; Quattrocchi V; Schraner EM; Ackermann M; Fraefel C; Mattion N
Vaccine; 2010 Oct; 28(46):7363-72. PubMed ID: 20851082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
